Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: JoeinIowa who wrote (12207)	1/2/1999 6:46:00 PM
From: Tony van Werkhooven	Respond to of 29382

In contrast to alteon (altn), you may want to consider Pharmos (pars). PARS has 2 approved (approved 1998) opthalmic drugs, marketed by BOL. Cash from these drugs just starting up. A potential blockbuster based on its HU211 compound(see note below) is entering phase III as soon as a partner is identified- discussions underway, expected identification of partner in 1st. Q 1999. Finally, PARS has a tamoxifen analogue for preventive treatment of breast cancer which is expected to eliminate many of the side effects of the currently approved drug. This has a long way to go however- expected to enter Phase I in 1999. Any potential short term cash flow problems has been resolved through an arrangement where additional shares are sold (up to $10 Million) at the option of the company (in amount and timing, i.e. company cpould sell shares on a monthly basis, hence very different from a floorless). This equity financing arrangement provides additional leverage to the company in negotiating with a Phase III partner for HU211. Note: potential blockbuster- HU211, compound has application in trauma to the brain. Successful Phase II completed in 1998, if approved by FDA following phase III, the drug would be unique in the marketplace with potential market of $1 Billion. Both the SI and Yahoo threads are very active and have many knowledgeable participants from the industry and medical field. This stock, in my opinion, has the potential to come alive very stronly in 1999, as a phase III partner is announced. A yearend 1999 value of $8 (compared to current 1 5/8) would not be outside the range. I would suggest you consider PARS for your DD. The company has a website at pharmoscorp.com Tony

To: JoeinIowa who wrote (12207)	1/3/1999 11:35:00 AM
From: Sergio H	Read Replies (1) \| Respond to of 29382

Jose and David, thanks for the ALTN research. I think that you guys are rigjht on target in your analyses. The bad news is already factored in the stock and you guys have found a safe play. FA: It's currently selling at just below book value, but the stock has to be worth more than book when concidering the pipeline and the Company's connections. TA: Technically, volume at price bottoms is bullish. Amigo Sergio

To: JoeinIowa who wrote (12207)	1/11/1999 7:09:00 PM
From: Sergio H	Respond to of 29382

Amigos y Amigas OVRL was up strong today as it was featured in the Industry Snapshop section of IBD. We are still expecting more upside as the Co. is being featured in a growth conference this week, earnings are coming on the 13th and I would not be surprised to see another news release concering new product development. WAMC was featured in aheadofthestreet.com this morning. There was a lot of interest on this stock and I wanted to post the link. This stock was not researched by any of the 3 Amigos. CNGR picking up some steam. Lots of news is coming. Amigo update report will be published sometime this week. Thanks for any support that anyone has cared to offer in my battle against Auric Goldfinger. I certainly am capable of turning the other cheek but why should Auric get away with bullying his way through SI? There are readers that actually believe his nonsense. For the sake of bullying a bully, Auric's record for today: Sunday, Jan 10 1999 8:53PM ET Reply # of 2070 Anyone wishing to see the Short Alert Research Report on SRCM should contact that firm at 704 543 4880. The report is comprehensive and covers what the bull story is, everything you always wanted to know about the Interactive Channel (and its lack of any apparent demand), the massive an credible competition that SRCM faces, the financial black hole that sRCM is in and Management (including their sale of 1.4 millions shares over the past year). Excellent bedside reading material. Message 7205366 RESULT: SRCM UP ALMOST 4 POINTS !!!! Reply # of 9105 This is a fraud stock thread not an advertising medium. Message 7221270 He's been taunting that thread for a while. RESULT: FIBR UP ALMOST 1 POINT !!!!!! He took a flat on IFLY. That's it. Lol

To: JoeinIowa who wrote (12207)	1/13/1999 6:21:00 PM
From: Sergio H	Read Replies (2) \| Respond to of 29382

<CNGR> NEWS IS COMING. * A move to the Nasdaq National Market from the Small Cap market. * A road show to spread the word about the company and bring exposure to the stock. * An additional 70K Inktomi shares were sold for almost $10 million. * Expected closing on the America's Car-Mart deal in mid January. * Expansion of PAACO into Houston. At least three new sites are expected for 1999. * Opening their first extended stay hotel, with a second to follow within weeks. Amigo's update at: smallcapforum.com Everyone including Amigo Auric can access it there. If Auric doesn't like it, rush out and buy as much of this stock as you can tomorrow at opening.